| Primary |
| Product Used For Unknown Indication |
58.5% |
| Pain |
12.4% |
| Drug Use For Unknown Indication |
10.8% |
| Drug Abuse |
8.5% |
| Back Pain |
1.5% |
| Bipolar Disorder |
1.4% |
| Arthralgia |
0.8% |
| Prophylaxis |
0.8% |
| Scoliosis |
0.8% |
| Fibromyalgia |
0.6% |
| Sciatica |
0.6% |
| Abdominal Pain |
0.4% |
| Ankylosing Spondylitis |
0.4% |
| Anxiety |
0.4% |
| Asthma |
0.4% |
| Breakthrough Pain |
0.4% |
| Emphysema |
0.4% |
| Hypertension |
0.4% |
| Intervertebral Disc Protrusion |
0.4% |
| Non-small Cell Lung Cancer |
0.4% |
|
| Drug Ineffective |
11.3% |
| Substance Abuse |
8.7% |
| Drug Hypersensitivity |
8.0% |
| Drug Abuse |
7.3% |
| Pruritus |
6.7% |
| Nausea |
5.3% |
| Overdose |
5.3% |
| Somnolence |
5.3% |
| Vomiting |
5.3% |
| Accidental Overdose |
4.7% |
| Drug Dependence |
4.7% |
| Inadequate Analgesia |
4.7% |
| Rash |
4.0% |
| Malaise |
3.3% |
| Urticaria |
3.3% |
| Drug Intolerance |
2.7% |
| Hallucination |
2.7% |
| Sedation |
2.7% |
| Atrial Fibrillation |
2.0% |
| Intentional Overdose |
2.0% |
|
| Secondary |
| Product Used For Unknown Indication |
30.0% |
| Pain |
20.2% |
| Drug Abuse |
11.3% |
| Back Pain |
9.5% |
| Drug Use For Unknown Indication |
7.3% |
| Neck Pain |
3.7% |
| Musculoskeletal Pain |
3.1% |
| Foetal Exposure During Pregnancy |
2.1% |
| Ankle Fracture |
1.8% |
| Anxiety |
1.5% |
| Analgesic Therapy |
1.2% |
| Chest Pain |
1.2% |
| Insomnia |
1.2% |
| Breakthrough Pain |
0.9% |
| Muscle Spasms |
0.9% |
| Nerve Injury |
0.9% |
| Osteoarthritis |
0.9% |
| Pelvic Inflammatory Disease |
0.9% |
| Ankylosing Spondylitis |
0.6% |
| Cancer Pain |
0.6% |
|
| Drug Abuse |
14.1% |
| Substance Abuse |
12.5% |
| Pain In Extremity |
6.3% |
| Pneumonia |
6.3% |
| Somnolence |
6.3% |
| Vomiting |
6.3% |
| Inadequate Analgesia |
4.7% |
| Pain |
4.7% |
| Road Traffic Accident |
4.7% |
| Depression |
3.1% |
| Drug Hypersensitivity |
3.1% |
| Drug Ineffective |
3.1% |
| Gallbladder Disorder |
3.1% |
| Malaise |
3.1% |
| Respiratory Arrest |
3.1% |
| Sedation |
3.1% |
| Tenderness |
3.1% |
| Thyroid Function Test Abnormal |
3.1% |
| Tremor |
3.1% |
| Unevaluable Event |
3.1% |
|
| Concomitant |
| Product Used For Unknown Indication |
46.0% |
| Drug Use For Unknown Indication |
19.8% |
| Pain |
10.7% |
| Small Cell Lung Cancer Stage Unspecified |
5.3% |
| Back Pain |
4.3% |
| Breakthrough Pain |
2.7% |
| Analgesic Therapy |
2.1% |
| Musculoskeletal Discomfort |
2.1% |
| Cancer Pain |
1.1% |
| Pain In Extremity |
1.1% |
| Antifungal Prophylaxis |
0.5% |
| Anxiety |
0.5% |
| Attention Deficit/hyperactivity Disorder |
0.5% |
| Cardiac Disorder |
0.5% |
| Compression Fracture |
0.5% |
| Graft Versus Host Disease |
0.5% |
| Mucosal Inflammation |
0.5% |
| Procedural Pain |
0.5% |
| Prophylaxis |
0.5% |
|
| Somnolence |
20.7% |
| Drug Effect Decreased |
13.8% |
| Product Adhesion Issue |
6.9% |
| Rash |
6.9% |
| Application Site Vesicles |
3.4% |
| Breakthrough Pain |
3.4% |
| Delirium |
3.4% |
| Drug Dependence |
3.4% |
| Fatigue |
3.4% |
| Headache |
3.4% |
| Hyperhidrosis |
3.4% |
| Inadequate Analgesia |
3.4% |
| Inappropriate Antidiuretic Hormone Secretion |
3.4% |
| Incorrect Dose Administered |
3.4% |
| Nausea |
3.4% |
| Product Solubility Abnormal |
3.4% |
| Unevaluable Event |
3.4% |
| Visual Acuity Reduced |
3.4% |
| Wound Infection |
3.4% |
|
| Interacting |
| Product Used For Unknown Indication |
75.0% |
| Erythromelalgia |
25.0% |
|
|
